TFDA-2024-0051-V351
Type II variation for application TFDA-2024-0051. Type II variation: Container Closure Change for Lorlatenilib — critical change
Variation Number
TFDA-2024-0051-V351
Type
Type II
Application
Change
Status
Submitted
Fee
€12,759
Submitted
2022-12-05
Approved
—
Description
Type II variation: Container Closure Change for Lorlatenilib — critical change